U

investors

With a rapidly growing business in Europe and plans for a future launch in the US, Sedana Medical is well-positioned for the future.

We are well on the way to our vision of making inhaled sedation a standard therapy in critical care.

The Share

Press Releases

2025

2025-11-24 08:00
Regulatory MAR
Sedana Medical AB (publ) announces that the company has completed its pre-NDA meeting with FDA and reached broad alignment with the Agency on the contents...
2025-10-24 07:00
Regulatory MAR
Improved EBITDA performance amid Q3 market headwinds Third quarter 2025 January-September 2025 CEO comments Improved EBITDA performance amid Q3 market...
2025-10-16 18:00
Regulatory
According to the principles for the appointment of the Nomination Committee in Sedana Medical AB (publ), the Nomination Committee for the Annual General...

Financial Reports

Financial Calendar